scispace - formally typeset
C

Catherine A. A. Beauchemin

Researcher at Ryerson University

Publications -  57
Citations -  2742

Catherine A. A. Beauchemin is an academic researcher from Ryerson University. The author has contributed to research in topics: Virus & Influenza A virus. The author has an hindex of 26, co-authored 48 publications receiving 2382 citations. Previous affiliations of Catherine A. A. Beauchemin include University of New Mexico & Los Alamos National Laboratory.

Papers
More filters
Journal ArticleDOI

Kinetics of Influenza A Virus Infection in Humans

TL;DR: A series of mathematical models of increasing complexity, which incorporate target cell limitation and the innate interferon response, are utilized to examine influenza A virus kinetics in the upper respiratory tracts of experimentally infected adults to suggest that antiviral treatments have a large hurdle to overcome in moderating symptoms and limiting infectiousness.
Journal ArticleDOI

A review of mathematical models of influenza A infections within a host or cell culture: lessons learned and challenges ahead

TL;DR: This work explores the symbiotic role of mathematical models and experimental assays in improving the quantitative understanding of influenza infection dynamics, and discusses the challenges in developing better, more comprehensive models for the course of influenza infections within a host or cell culture.
Journal ArticleDOI

Agent-based modeling of host-pathogen systems: The successes and challenges

TL;DR: Various agent-based models relevant to host–pathogen systems and their contributions to the authors' understanding of biological processes are reviewed and some limitations and challenges are pointed out.
Journal ArticleDOI

A simple cellular automaton model for influenza A viral infections

TL;DR: A simple 2-D cellular automaton (CA) model of a viral infection has been developed and is validated against clinical immunological data for uncomplicated influenza A infections.
Journal ArticleDOI

Modeling amantadine treatment of influenza A virus in vitro.

TL;DR: It is found that influenza A/Albany/1/98 (H3N2) virions under normal experimental conditions at 37 degrees C rapidly lose infectivity with a half-life of approximately 6.6+/-0.2 h, and that the lifespan of productively infected MDCK cells is approximately 13 h.